These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1380224)
21. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor. Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727 [TBL] [Abstract][Full Text] [Related]
22. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916 [TBL] [Abstract][Full Text] [Related]
23. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238 [TBL] [Abstract][Full Text] [Related]
24. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells. van Besien K; Margolin K; Champlin R; Forman S Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395 [TBL] [Abstract][Full Text] [Related]
25. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease. Weaver CH; Schwartzberg L; Li W; Hazelton B; West W Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687 [TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
28. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy. Laughlin MJ; Christiansen NP; Herzig GP; Blumenson L; Bonney D; Stewart CC Cytometry; 1996 Dec; 26(4):235-42. PubMed ID: 8979021 [TBL] [Abstract][Full Text] [Related]
29. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Brice P; Divine M; Marolleau JP; Haioun C; Dalcortivo L; Sitthy X; Beaujean F; Norol F; Benbunan M; Reyes F Bone Marrow Transplant; 1994 Jul; 14(1):51-5. PubMed ID: 7524907 [TBL] [Abstract][Full Text] [Related]
30. Peripheral blood stem cells: in vivo biology and therapeutic potential. Scheding S; Brugger W; Mertelsmann R; Kanz L Stem Cells; 1994; 12 Suppl 1():203-10; discussion 211. PubMed ID: 7535146 [TBL] [Abstract][Full Text] [Related]
31. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma]. Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076 [TBL] [Abstract][Full Text] [Related]
37. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation. Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509 [TBL] [Abstract][Full Text] [Related]
38. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347 [TBL] [Abstract][Full Text] [Related]
39. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592 [TBL] [Abstract][Full Text] [Related]